Certara is a Nasdaq-listed (CERT) biosimulation and drug development company that helps scientists and clinical teams generate regulatory-grade evidence faster. Its offerings combine biosimulation software, clinical intelligence, regulatory science, technology and consulting services, embedded in drug developers' workflows from discovery through regulatory submission. Clients include more than 2,400 biopharmaceutical companies, academic institutions and regulatory agencies across 70 countries, with offices across North America, Europe and Asia-Pacific.